Patents by Inventor Henry W. Talbot

Henry W. Talbot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High level expression of recombinant toxin proteins
    Patent number: 8530171
    Abstract: The present invention relates to the field of recombinant toxin protein production in bacterial hosts. In particular, the present invention relates to production processes for obtaining high levels of a recombinant CRM197, Diphtheria Toxin, Pertussis Toxin, Tetanus Toxoid Fragment C, Cholera Toxin B, Cholera holotoxin, and Pseudomonas Exotoxin A, from a bacterial host.
    Type: Grant
    Filed: March 28, 2011
    Date of Patent: September 10, 2013
    Assignee: Pfenex Inc.
    Inventors: Diane M. Retallack, Lawrence Chew, Hongfan Jin, Henry W. Talbot
  • HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS
    Publication number: 20110287443
    Abstract: The present invention relates to the field of recombinant toxin protein production in bacterial hosts. In particular, the present invention relates to production processes for obtaining high levels of a recombinant CRM197, Diphtheria Toxin, Pertussis Toxin, Tetanus Toxoid Fragment C, Cholera Toxin B, Cholera holotoxin, and Pseudomonas Exotoxin A, from a bacterial host.
    Type: Application
    Filed: March 28, 2011
    Publication date: November 24, 2011
    Applicant: Pfenex Inc.
    Inventors: Diane M. Retallack, Lawrence Chew, Hongfan Jin, Henry W. Talbot
  • Novel lepidopteran-active Bacillus thuringiensis isolate
    Patent number: 4990332
    Abstract: The subject invention concerns a novel and useful insecticide with activity against insect pests of the order Lepidoptera. Pests in the order Lepidoptera do heavy damage to crops, e.g., cabbage and broccoli. The insecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS85A1, or mutants thereof. Specifically disclosed is an asporogenous mutant designated B.t. PS85A1-168. The spores or crystals of B.t. PS85A1, or the crystals of B.t. PS85A1-168, are useful to control lepidopteran pests in various environments.
    Type: Grant
    Filed: October 25, 1988
    Date of Patent: February 5, 1991
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, George G. Soares, Henry W. Talbot, Theresa C. Olson